HOME >> BIOLOGY >> NEWS
March of Dimes awards $250,000 prize to pioneering scientist

SAN FRANCISCO, MAY 3, 2004 One of the 20th century's most influential female scientists, Mary F. Lyon, Ph.D., whose discovery of the process of X-chromosome inactivation unlocked a central mystery underlying many inherited birth defects and diseases, has been awarded the 2004 March of Dimes Prize in Developmental Biology.

"Dr. Lyon's recognition in 1961 of X-chromosome inactivation, which is still referred to as 'Lyonization,' was one of the first great insights into genetic control mechanisms of the 20th century," said Dr. Jennifer L. Howse, president of the March of Dimes. "This was the key to understanding the inheritance pattern of X-linked disorders such as hemophilia, Duchenne muscular dystrophy, fragile X syndrome, and certain types of cancer. As a result of Dr. Lyon's work, it became possible to provide accurate tests and genetic counseling for families affected by these disorders and to begin the research into potential treatments that continues today."

"In addition, Dr. Lyon's pioneering work became a model for the study of gene regulation and has had an enormous influence on the work of many other scientists for the past 40 years," Dr. Howse said.

The Prize is a cash award of $250,000 and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes.

The human genome consists of 23 pairs of chromosomes, the string-like structures in the nuclei of our cells that contain the genes. Twenty-two of these pairs are known as autosomes and are identical in males and females. Inheriting an excess number of an autosome can result in the death of an embryo or drastic health consequences.

The remaining pair of chromosomes, known as the sex chromosomes, are designated by the letters X and Y. Males have one X chromosome and one Y chromosome, while female
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
3-May-2004


Page: 1 2 3

Related biology news :

1. March of Dimes statement on newborn screening report
2. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
3. Only 21 states offer newborn screening tests recommended by March of Dimes
4. Nanotechnology highlights from the ACS national meeting in Anaheim, Calif., March 28-April 1
5. Media advisory: Sea of Cortez expedition to launch March 26
6. Other highlights of the March 17 issue of JNCI
7. JCI table of contents, 15 March 2004
8. USGS March science picks
9. Other highlights in the March 3 issue of JNCI
10. JCI table of contents, March 1 2004
11. 2nd Annual CDB Symposium: Developmental Remodeling (March 29 - 31, 2004; Kobe, Japan)

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: March Dimes awards prize pioneering scientist

(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) explores ... the impact of coffee on autoimmune disease and palliative ... recently has been associated with reduced risk of fibrosis, ... cups of java each month also correlate with lower ... the Mayo Clinic, Rochester, MN, linked coffee consumption with ...
(Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
(Date:5/17/2013)... climate change may have little impact on many ... recent studies that predict their widespread extinction in ... appear in the journal Global Change Biology ... creature thought to be doomed: http://onlinelibrary.wiley.com/doi/10.1111/gcb.12253/abstract ... forest lizards, will be hard hit by climate ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3Climate change may have little impact on tropical lizards 2
(Date:5/20/2013)... May 21, 2013 Grace Century ... in “game-changing” life science and health related private equity ... to its International Project Team. Dergham's expertise in finance ... multi-cultural depth to Grace Century as it continues to ... , Ms. Dergham holds both an under graduate degree ...
(Date:5/20/2013)... Calif. , May 20, 2013  (PSHR) ... providing naturally based products across a broad range ... company has retained investor relations firm, BlueWater Advisory ... the return to trading process, and to direct ... trading initiation. Matthew Mills ...
(Date:5/20/2013)... , Md. and BALTIMORE , May ... (BHI), a regional private-public partnership focusing on commercializing ... funding in Central Maryland , ... M.B.A., as the first Entrepreneur-in-Residence (EIR) for BHI ... National Heart, Lung and Blood Institute (NHLBI). ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his colleagues ... Institute have helped pioneer many breakthroughs in the ... the past three decades, from new disease-fighting medications to ... stent implantation. , Today, AGH officials announced that the ... the study of a novel, first-of-its kind investigational device ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
Cached News: